logo
Sign In
  1. Home
  2. Manufacturers
  3. AbbVie Inc.

AbbVie Inc. drugs

FiltersReset Filters
32 results
  • creon

    (Pancrelipase)
    Medication Details
    AbbVie Inc.
    Usage: CREON® is indicated for treating exocrine pancreatic insufficiency in both adult and pediatric patients.
    Medication Details
  • depakote - divalproex sodium tablet, delayed release

    (Divalproex Sodium)
    Medication Details
    Abbvie Inc.
    Medication Details
    Drug Interactions
  • depakote er - divalproex sodium tablet, extended release

    (Divalproex Sodium)
    Medication Details
    Abbvie Inc.
    Medication Details
    Drug Interactions
  • depakote sprinkles - divalproex sodium capsule

    (Divalproex Sodium)
    Medication Details
    Abbvie Inc.
    Medication Details
    Drug Interactions
  • duopa

    (Carbidopa and Levodopa)
    Medication Details
    AbbVie Inc.
    Usage: DUOPA® is indicated for treating motor fluctuations in patients with advanced Parkinson’s disease.
    Medication Details
    Drug Interactions
  • emblaveo - aztreonam and avibactam powder, for solution

    (Aztreonam And Avibactam)
    Medication Details
    Abbvie Inc.
    Medication Details
  • emrelis

    (Telisotuzumab Vedotin)
    Medication Details
    AbbVie Inc.
    Usage: EMRELIS is indicated for adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) exhibiting high c-Met protein overexpression (≥50% of tumor cells). It is for those who have previously received systemic therapy and is approved under accelerated conditions based on overall response rate.
    Medication Details
    Drug Interactions
  • gengraf

    (Cyclosporine)
    Medication Details
    AbbVie Inc.
    Usage: Gengraf® (cyclosporine oral solution, USP [MODIFIED]) is indicated for the prevention of organ rejection in kidney, liver, and heart transplants, as well as for treating severe active rheumatoid arthritis unresponsive to methotrexate and severe plaque psoriasis in adults who have failed prior systemic therapies.
    Medication Details
    Drug Interactions
  • gengraf - cyclosporine capsule

    (Cyclosporine)
    Medication Details
    Abbvie Inc.
    Medication Details
  • humira - adalimumab

    (Adalimumab)
    Medication Details
    Abbvie Inc.
    Medication Details
    Drug Interactions
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.